156A Week 10

Overview of Status of Analysis, Design, Fabrication, Tests, etc.

• Still in brainstorming phase but narrowing to a few design choices.

Accomplishments from Previous Week

• Phase one of iterative brainstorming

• Before next meeting with sponsor, tasked with research:

  • John, Tejas, Archana, Ryan: Various existing approaches and technologies to measure stress and strain (can be biological tissues or non-biological tissues)

    • 3 examples (or more)

  • John, Tejas, Archana, Ryan: A tentative list of constraints that you think may be relevant to an eventual design.

    • 5 examples (or more)

• John, Tejas, Archana, Ryan: Worked on individual component analysis

• John, Tejas, Archana, Ryan: Began working on risk reduction presentation

Goals for Next Week (list names after each item). Use specific and measurable objectives.

• Phase two of iterative brainstorming:

  • John, Tejas, Archana, Ryan: Research two new methods of stress analysis mentioned by sponsor

  • John, Tejas, Archana, Ryan: Research methods of visual strain analysis

  • Archana: Combine constraints into streamlined list

    • Apply constraints to research methods

    • Apply feasibility analysis

      • List yes, no, or maybe

• John, Tejas, Archana, Ryan: Finish individual component analysis

• John, Tejas, Archana, Ryan: Finish risk reduction presentation, practice presentation

Sponsor Comments from Last Meeting and Actions Taken to Address these Comments (indicate date of comments and if via email or in person)

• Presented research topics

  • Discussed several current methods of obtain strain/stress in tissue

  • Discussed potential constraints and concerns for new device

• Sponsor presented more background information

  • Explained process of sensing tension “by feel”

• Went over problem description and risk reduction presentation outlines

  • Laid out specific milestones to create for gantt chart

Instructor Comments from Last Meeting and Actions Taken to Address these Comments (indicate date of comments and if via email or in person)

• Went over progress report, activities of past week

• Went over risk reduction concepts → would be purely analysis

  • Cleared up individual component analysis and risk reduction questions

Comments from Other Students in the Class (indicate date of comments and if via email or in person)

• N/A

Risks and Areas of Concern

• Our design needs to be biocompatible.

• Our design needs to be designed for FDA approval.

Resources or Information Required but not Available

• N/A

Schedule

• • Risk Reduction Report

  • Individual Component Analysis

  • Update Gantt chart.

Budget (list amount spent and amount remaining)

• Amount Spent: $0

• Amount Remaining: $2600

Progress on Report and Webpage

• A shell report has been created for our Risk Reduction Report.